5- lipoxygenase pathway genes polymorphisms in Egyptian patients with bronchial asthma / Maha Hosni Ibraheem ; Supervised Amal Abdelwahab Mohammed , Hanan Ali Madani , Wafaa Ashour
Material type:
- التنوع الشكلى لمسار جين ال٥ مؤكسد الدهون فى مرضى الربو الشعبى المصريين [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.Ph.D.2014.Ma.F (Browse shelf(Opens below)) | Not for loan | 01010110064359000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.Ph.D.2014.Ma.F (Browse shelf(Opens below)) | 64359.CD | Not for loan | 01020110064359000 |
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
Bronchial asthma (BA) is a chronic disorder of the airways. 5- lipoxygenase (5 - LO) play an essential role in the biosynthesis of leukotrienes that induce proinflammatory actions. The aim of this study was to determine the 5- lipoxygenase (5 - LO) pathway polymorphisms in asthmatic patients and to understand their role in the pathophysiology of BA. 50 asthmatic patients and 30 controls were included in this study. 3 genes were studied (LTC4S - 444A / C using polymerase chain reaction / Restriction fragment length polymorphism (PCR / RFLP), ALOX5 - 176 / - 147 using fragment length analysis and ALOX5AP - 169 / - 146 by real time PCR). There was statistically significant increase in the mutant genotype of ALOX5AP - 169 - 146 gene among the patients group compared to the control group (P = 0.004) with 4.5 times risk of bronchial asthma among those carrying the mutant {u2018}357{u2019} allele of Alox5AP{u2013}169{u2013}146 gene OR = 4.529, 95% CI = 1.7 - 12.018, P < 0.001
Issued also as CD
There are no comments on this title.